Vor biopharma inc.

Major-Pharmaceuticals

VOR


Executive/
Director

Price

  • Last Close
  • $ 0.86
    $ -0.01 -0.69 %
    Aug 29, 2024
  • 52-Week High/Low
  • $2.85 - $0.81
  • YTD
  • -61.7%

  • Trading Volume
  • 4,235
  • Market Cap Full
  • $ 58.3M
  • Shares Outstanding
  • 67.8M
    Nov 7, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - - - - - -49.2% -19.1% 5.3%
Q2 - - - - - - -56.7% -17.7% -42.6% -5%
Q3 - - - - - - -15.2% -19.9% -31.4% -
Q4 - - - - - - -24.8% 67.1% 15.1% -
J F M A M J J A S O N D
2024 2.2% - 3% -11.8% - - - - - - - -
2023 -20.8% 5.9% -3.6% -17.3% 5.6% -34.3% -2.3% -17.2% -15.2% -13.7% 1.1% 21.6%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%0%0%0%0%-44%-66%-62%

Earnings

2021 2022 2023
Q1 -0.67 -0.61 -0.43
Q2 -0.5 -0.58 -0.45
Q3 -0.5 -0.63 -0.49
Q4 -0.49 -0.53 -
A -2.1 -2.3 -1.37

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2021 2022 2023
Mar - 37.5 66.4
Jun 37.1 37.6 67
Sep 37.1 38.1 67.5
Dec 37.3 38.7 67.8

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage - - - - -
Equity multiplier - - - - -